The costs to the world's second-biggest economy mount. Some 23...
Category:
Pandemic
Latest
Thailand cancels licenses of 2 P/C insurers
The firms were in serious financial trouble, which could have...
PSU insurers lodge Covid insurance claims worth Rs 17,537 cr till Dec 2021
''Till December 31, 2021, 14.92 lakh COVID-19 health claims, of a...
No link found so far between menstrual disorders and COVID-19 vaccines, EU says
Menstrual disorders can occur for various reasons, from stress and tiredness to underlying medical conditions such as fibroids and endometriosis.
The EU agency stressed that benefits of J&J’s vaccine still outweighed any risks, adding that it had analysed 1,183 cases of dizziness and more than 100 cases of tinnitus to reach its conclusion.
HC seeks Delhi govt, IRDA stand on plea against insurance co not paying full claim on Covid death
The plea further sought to direct the IRDA to take strict action against the insurance firm for violating its guidelines, framed for insurers to include the expense incurred on hospitalization and treatment of COVID-19 patients, and to ensure its compliance so that no insurer may escape from their liability of making payment.
India gave priority to poor in its strategy to combat COVID-19 crisis: PM Modi
He noted that over 80 crore citizens have been provided free ration after the COVID-19 started in the country.
“Not just wheat, rice or pulses but over 8 crore poor families were even provided free gas cylinders during the lockdown. Over 20 crore women received around Rs 30,000 crores directly in their Jan Dhan bank accounts,” the Prime Minister stated.
Johnson & Johnson’s single-dose COVID-19 vaccine gets Emergency Use approval in India
The five vaccines granted Emergency Use Authorisation in India are Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, Moderna, and now Johnson & Johnson (J&J).
India sees single-day rise of 38,628 New Coronavirus cases, 617 fresh deaths
Cumulative vaccine doses administered so far has reached 50.10 crore under the nationwide vaccination drive
United States now averaging 100,000 new Covid-19 infections a day
The virus is spreading quickly through unvaccinated populations, especially in the Deep South. Florida, Louisiana and Mississippi have had hospitals overrun with patients.
The US first crossed the 100,000 average number in November and peaked at about 250,000 in early January before bottoming out in late June.
Heart, stroke risks climb after COVID-19; flu shots may be protective
In the week following a COVID-19 diagnosis, the risk of a first heart attack went up three- to eight-fold, and the risk of a first stroke due to a blood-vessel blockage rose three- to six-fold, the researchers found.
No work, no food: Pandemic deepens global hunger
The World Food Program sounded the alarm further last week in a joint report with the UN’s Food and Agriculture Organization, warning that “conflict, the economic repercussions of Covid-19 and the climate crisis are expected to drive higher levels of acute food insecurity in 23 hunger hot spots over the next four months,” mostly in Africa but also Central America, Afghanistan and North Korea.
Downbeat Indian consumers withhold spending amid pandemic, says RBI survey
“The sentiments on overall spending remained unchanged as higher spending on essential items were offset by a drop in non-essential expenditure with consumers expecting further contraction in discretionary expenditure in the year ahead,” the RBI said.
With forecasters warning of a third wave, any new restrictions could spell more bad news for the country, where private consumption makes up some 60% of gross domestic product.
J&J seeks emergency use nod for COVID-19 vaccine in India
Indian health authorities have so far approved the use of vaccines developed by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute and Moderna.
The government and Moderna are still trying to sort out issues over imports of the vaccine and indemnity, a top executive at Indian drugmaker and Moderna’s local distribution partner Cipla told Reuters in an interview on Friday.